Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Exenatide

    Client Email Product

    Exenatide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    CLINICAL TRIALS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    18
    US DMFs Filed

    US DMFs Filed

    9
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    1
    Other Suppliers

    Other Suppliers

    11
    API REF. PRICE (USD / KG)

    0

    API Market Place

    8
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    15
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    6
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    600.00

    Annual Reports

    710.00

    FDF Market Place

    0

    EXCIPIENTS
    48
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    23
    REF STANDARD

    EDQM

    0

    USP

    1

    JP

    0

    Other Listed Suppliers

    6
    SERVICES

    0

    Full View ScreenFull Screen View
    UK probes GLP-1 drugs' potential suicide risks
    UK probes GLP-1 drugs' potential suicide risks

    https://www.fiercepharma.com/pharma/glp-1-drugs-novo-az-lilly-and-sanofi-under-uk-probe-over-their-suicide-risks-reuters

    Angus Liu FIERCE PHARMA
    27 Jul 2023
    Share Share
    AstraZeneca's once-weekly diabetes drug gets U.S. nod for children
    AstraZeneca's once-weekly diabetes drug gets U.S. nod for children

    https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-weekly-once-diabetes-drug-gets-us-approval-children-2021-07-23/

    REUTERS
    27 Jul 2021
    Share Share
    AstraZeneca sales hurt by Bydureon Bcise production constraints
    AstraZeneca sales hurt by Bydureon Bcise production constraints

    HTTPS://WWW.IN-PHARMATECHNOLOGIST.COM/ARTICLE/2019/11/04/ASTRAZENECA-SALES-HURT-BY-BYDUREON-BCISE-PRODUCTION-CONSTRAINTS

    N. Taylor IN PHARMATECNOLOGISTS
    03 Nov 2019
    Share Share
    Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics
    Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics

    https://www.fiercebiotech.com/biotech/longtime-alkermes-exec-elliot-ehrich-joins-expansion-therapeutics

    Amirah Al Idrus FIERCE BIOTECH
    13 Nov 2018
    Share Share
    Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk
    Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk

    https://www.xconomy.com/indiana/2018/09/27/eli-lilly-strikes-deal-for-diabetes-pill-to-gain-on-novo-nordisk/

    XCONOMY
    27 Sep 2018
    Share Share
    EU approves AZ’ Bydureon BCise device
    EU approves AZ’ Bydureon BCise device

    http://www.pharmatimes.com/news/eu_approves_az_bydureon_bcise_device_1250738

    Selina McKee PHARMA TIMES
    30 Aug 2018
    Share Share
    Repurposing a diabetes drug to slow Parkinson’s
    Repurposing a diabetes drug to slow Parkinson’s

    https://www.fiercebiotech.com/research/repurposing-glp-1-diabetes-drug-to-slow-parkinson-s-disease

    Bradley J. Fikes FIERCE BIOTECH
    23 Jul 2018
    Share Share
    Type 2 diabetes research: fewer side effects from modified medication
    Type 2 diabetes research: fewer side effects from modified medication

    https://pharmaphorum.com/news/diabetes-research-modified-medication/

    PHARMAPHORUM
    18 Jul 2018
    Share Share
    New SR Exendin-4 Formulation proves effective against Parkinson's
    New SR Exendin-4 Formulation proves effective against Parkinson's

    https://www.biospectrumasia.com/news/25/11292/new-sr-exendin-4-formulation-proves-effective-against-parkinsons.html

    BIOSPECTRUM
    16 Jul 2018
    Share Share
    AZ hopes diabetes drug could be as effective as gastric band
    AZ hopes diabetes drug could be as effective as gastric band

    https://pharmaphorum.com/news/az-hopes-diabetes-drug-could-be-as-effective-as-gastric-band/

    PHARMA PHORUM
    11 Jul 2018
    Share Share
    Dr. Reddy's and its US. subsidiary Promius announce the filing NDA for migraine
    Dr. Reddy's and its US. subsidiary Promius announce the filing NDA for migraine

    https://www.businesswire.com/news/home/20180402005384/en

    BUSINESSWIRE
    02 Apr 2018
    Share Share
    Stampeding generics expected to trample Lilly's now-off-patent med Strattera
    Stampeding generics expected to trample Lilly's now-off-patent med Strattera

    http://www.fiercepharma.com/pharma/lilly-s-adhd-med-strattera-faces-new-generic-competition-from-teva-and-others

    Eric Sagonowsky FIERCE PHARMA
    01 Jun 2017
    Share Share
    US FDA accepts Intarcia's NDA for ITCA 650 to treat type 2 diabetes
    US FDA accepts Intarcia's NDA for ITCA 650 to treat type 2 diabetes

    http://www.pharmabiz.com/NewsDetails.aspx?aid=100224&sid=2

    PHARMABIZ
    07 Feb 2017
    Share Share
    Intarcia’s under skin mini-pump accepted by FDA
    Intarcia’s under skin mini-pump accepted by FDA

    http://pharmaphorum.com/news/intarcias-mini-pump-gets-fda-go-ahead-type-2-diabetes/

    PHARMA PHORUM
    06 Feb 2017
    Share Share
    Glide raises £3.2m for solid dose injector programme
    Glide raises £3.2m for solid dose injector programme

    http://www.pharmatimes.com/news/glide_raises_3.2m_for_solid_dose_injector_programme_1185653

    Selina McKee PHARMATIMES
    02 Feb 2017
    Share Share
    Platypus venom could give rise to a new class of diabetes treatments
    Platypus venom could give rise to a new class of diabetes treatments

    http://www.fiercebiotech.com/research/platypus-venom-could-give-rise-to-a-new-class-diabetes-treatments

    Amirah Al Idrus FIERCE BIOTECH
    30 Nov 2016
    Share Share
    Oramed Vs. Novo Nordisk In Race For Oral GLP-1
    Oramed Vs. Novo Nordisk In Race For Oral GLP-1

    http://www.nasdaq.com/article/oramed-vs-novo-nordisk-in-race-for-oral-glp-1-cm715418

    NASDAQ
    29 Nov 2016
    Share Share
    AZ Taps 3SBio to Help Drive Sales of Diabetes Meds Byetta, Bydureon in China
    AZ Taps 3SBio to Help Drive Sales of Diabetes Meds Byetta, Bydureon in China

    http://www.fiercepharma.com/pharma-asia/az-taps-3sbio-for-help-driving-sales-two-diabetes-drugs-china

     Phil Taylor FIERCE PHARMA
    14 Oct 2016
    Share Share
    Eli Lilly spurns a PhIII-ready diabetes drug, and Transition tanks
    Eli Lilly spurns a PhIII-ready diabetes drug, and Transition tanks

    http://www.fiercebiotech.com/biotech/eli-lilly-spurns-a-phiii-ready-diabetes-drug-and-transition-tanks-again

    John Carroll FIERCE BIOTECH
    19 Apr 2016
    Share Share
    Glide Announce Successful Proof-of-Concept With Novel Exenatide Formulation
    Glide Announce Successful Proof-of-Concept With Novel Exenatide Formulation

    http://www.prnewswire.com/news-releases/glide-technologies-announces-successful-proof-of-concept-with-novel-exenatide-solid-dose-formulation-564345691.html

    PR NEWS WIRE
    05 Jan 2016
    Share Share
    Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
    Should FDA Penalize Drug Makers Over Diabetes Drug Ads?

    http://blogs.wsj.com/pharmalot/2015/04/01/should-fda-penalize-drug-makers-over-diabetes-drug-ads/

    Ed Silverman PHARMALOT
    01 Apr 2015
    Share Share
    Sanofi's Diabetes Franchise One Step Closer To U.S. Lyxumia Launch
    Sanofi's Diabetes Franchise One Step Closer To U.S. Lyxumia Launch

    http://www.fiercepharma.com/story/sanofis-diabetes-franchise-one-step-closer-us-lyxumia-launch/2015-03-19

    Tracy Staton FIERCE PHARMA
    20 Mar 2015
    Share Share
    AZ launches Bydureon Pre-Filled Injector Pen in UK
    AZ launches Bydureon Pre-Filled Injector Pen in UK

    http://www.pharmatimes.com/Article/15-01-27/AZ_launches_Bydureon_pre-filled_injector_pen_in_UK.aspx

    Selina Mckee PHARMA TIMES
    27 Jan 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search